- Home
- GERN vs SHLS Comparison
GERN vs SHLS Comparison
Compare GERN & SHLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- SHLS
- Stock Information
- Founded
- GERN 1990
- SHLS 1996
- Country
- GERN United States
- SHLS United States
- Employees
- GERN N/A
- SHLS N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- SHLS Semiconductors
- Sector
- GERN Health Care
- SHLS Technology
- Exchange
- GERN Nasdaq
- SHLS Nasdaq
- Market Cap
- GERN 853.5M
- SHLS 850.9M
- IPO Year
- GERN 1996
- SHLS 2021
- Fundamental
- Price
- GERN $1.57
- SHLS $4.72
- Analyst Decision
- GERN Buy
- SHLS Buy
- Analyst Count
- GERN 9
- SHLS 24
- Target Price
- GERN $5.13
- SHLS $9.10
- AVG Volume (30 Days)
- GERN 13.0M
- SHLS 9.2M
- Earning Date
- GERN 05-07-2025
- SHLS 05-06-2025
- Dividend Yield
- GERN N/A
- SHLS N/A
- EPS Growth
- GERN N/A
- SHLS N/A
- EPS
- GERN N/A
- SHLS 0.11
- Revenue
- GERN $116,293,000.00
- SHLS $388,762,000.00
- Revenue This Year
- GERN $160.12
- SHLS $11.24
- Revenue Next Year
- GERN $55.01
- SHLS $11.79
- P/E Ratio
- GERN N/A
- SHLS $43.47
- Revenue Growth
- GERN 22264.04
- SHLS N/A
- 52 Week Low
- GERN $1.17
- SHLS $2.71
- 52 Week High
- GERN $5.34
- SHLS $8.52
- Technical
- Relative Strength Index (RSI)
- GERN 51.71
- SHLS 54.35
- Support Level
- GERN $1.30
- SHLS $4.28
- Resistance Level
- GERN $1.54
- SHLS $4.78
- Average True Range (ATR)
- GERN 0.11
- SHLS 0.42
- MACD
- GERN 0.03
- SHLS -0.10
- Stochastic Oscillator
- GERN 66.67
- SHLS 34.40
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About SHLS Shoals Technologies Group Inc.
Shoals Technologies Group is a provider of electrical balance of system solutions for solar energy projects, primarily in the United States. EBOS encompasses components that are necessary to carry electric current produced by solar panels to an inverter. The products are sold principally to engineering, procurement, and construction firms that build solar energy projects.